MARY HANEY: Open Payments
NPI 1124435961 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 46 payments from 9 companies in 2025. Trend: 2023 $703 · 2024 $228 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $558 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: RINVOQ, SKYRIZI, ENTYVIO, DUPIXENT, CREON, LINZESS, ZENPEP, TREMFYA.
Industry payments across PA — which companies pay providers there.
